title: Intrahepatic portal venopathy and related disorders of the liver.
abstract: Intrahepatic portal venopathy leads to various entities that are important causes of portal hypertension. Noncirrhotic portal fibrosis (NCPF) occurs in the Indian subcontinent, whereas idiopathic portal hypertension (IPH) occurs in Japan although the pathogenesis and presentation of both are similar. NCPF presents mainly with upper gastrointestinal bleeding; IPH presents with massive splenomegaly. The liver functions are preserved. Wedged hepatic venous pressure is normal, but portal venous pressure is high indicating a presinusoidal block. Patients are best managed with endoscopic therapy or surgery, with better results than in patients with cirrhosis. Nodular regenerative hyperplasia is a histological diagnosis characterized by development of nodules in the liver due to uneven perfusion of the portal venous blood. These patients may develop portal hypertension and if they bleed would require treatment as in NCPF/IPH. Schistosomiasis produces portal hypertension by the development of fibrous tissue around the portal veins as a response to schistosome eggs. Gratifying results have been reported with praziquantel therapy. Rarely sarcoidosis and chronic biliary obstruction may also produce portal venopathy.
authors.affiliation: Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. ykchawla@gmail.com
authors.forename: Yogesh
authors.initials: Y
authors.lastname: Chawla
authors.forename: Radha Krishan
authors.initials: RK
authors.lastname: Dhiman
mesh_terms: D000818:Animals; D002779:Cholestasis / Q000150:complications / Q000473:pathology; D005355:Fibrosis; D020518:Focal Nodular Hyperplasia / Q000150:complications / Q000473:pathology; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D008099:Liver / Q000098:blood supply*; D008107:Liver Diseases / Q000150:complications* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D017082:Portal Pressure; D011169:Portal Vein / Q000473:pathology* / Q000503:physiopathology; D012307:Risk Factors; D012507:Sarcoidosis / Q000150:complications / Q000473:pathology; D012552:Schistosomiasis / Q000150:complications / Q000473:pathology; D016896:Treatment Outcome; D014652:Vascular Diseases / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy